Investigation and Research on the Cognition Status of the National Centralized Drug Procurement Policy and the Demand for Pharmaceutical Care of Physicians in 14 Medical Institutions of Suzhou

OBJECTIVE To understand the promotion of the National Centralized Drug Procurement Policy(hereinafter referred to as "Centralized Procurement Policy"), give better play to the role of pharmaceutical care, and promote the transformation of pharmaceutical care through investigation and research on the cognition status of the Centralized Procurement Policy and the demand for pharmaceutical care of physicians in 14 medical institutions of Suzhou. METHODS From May to July 2021, the questionnaire star survey was used to investigate the Centralized Procurement Policy awareness, evaluation, medication behavior and the demand for pharmaceutical care of physicians in 14 medical institutions of Suzhou. The answers to each question were summarized and descriptively analyzed, and SPSS 25.0 statistical software was used for data analysis. RESULTS A total of 1 134 questionnaires were investigated, and 1 005 were effectively recovered. Awareness:there were 826 physicians who were aware of the Centralized Procurement Policy, and the awareness rate was 82.19%. The level of medical institutions, professional titles, educational backgrounds, and the times of the Centralized Procurement Policy training had statistical differences in the awareness of the Centralized Procurement Policy(P<0.05). The higher of the level of the medical institution, the higher of the professional title, the higher of the educational background, and the more times of Centralized Procurement Policy training, the higher the awareness rate of physicians. Evaluation:among the physicians who knew the Centralized Procurement Policy, 61.26% were satisfied with the therapeutic effect of the centralized purchasing drugs, and 69.49% of them were satisfied with the safety of the centralized purchasing drugs. Different educational backgrounds and the training times for the centralized purchasing drugs had statistical differences in the evaluation of the centralized purchasing drugs(P<0.05), among which physicians with specialized educational background were more satisfied with the centralized purchasing drugs; the more of training times, the higher the evaluation of the centralized purchasing drugs. Medication behavior:among the physicians who knew the Centralized Procurement Policy, 83.90% of them gave priority to the centralized purchasing drugs when issuing medical orders. There were statistically significant differences in medication behavior among different medical institution grades, educational backgrounds, and training times of the Centralized Procurement Policy(P<0.05). Physicians in first-level medical institutions would give priority to the centralized purchasing drugs when issuing medical orders; physicians with professional qualifications would be more active in understanding the Centralized Procurement Policy; the more times that physicians participated in the Centralized Procurement Policy training, the priority would be given to the centralized purchasing drugs when taking medication. Demand for pharmaceutical care:89.10% of physicians needed pharmacists to push popular science articles on the Centralized Procurement Policy and provided frontier information and progress of the centralized purchasing drugs, and 83.29% of physicians needed pharmacists to provide medical insurance policy information related to the centralized purchasing drugs. CONCLUSION The physicians in the 14 medical institutions of Suzhou have high awareness of the Centralized Procurement Policy and the demand for pharmaceutical care. Physicians and pharmacists should play more roles in the promotion of the Centralized Procurement Policy.